Home > News > Take 5 with Michael Poterala, executive director, MSU Technologies
January 7th, 2008
Take 5 with Michael Poterala, executive director, MSU Technologies
Abstract:
During the fiscal year that ended June 30, 2007, MSU received 35 U.S. patents, up from 21 for the 2005-06 fiscal year, Poterala said. MSU researchers submitted 161 invention disclosures during the 2006-07 fiscal year, up from 156 the year before. MSU entered into 17 new technology license agreements last year and 21 the previous year.
Poterala highlighted East Lansing startup company XG Sciences Inc. as a point of pride for MSU Technologies. The company licensed technology from MSU during the summer and in November was recognized by Nanotech Briefs, an online industry publication, for developing a new nanomaterial.
Source:
lsj.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||